Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain

September 9, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search